We collected information about Idra Stock After Hours for you. Follow the liks to find out everything about Idra Stock After Hours.
https://www.nasdaq.com/market-activity/stocks/idra/after-hours
Idera Pharmaceuticals, Inc. Common Stock (IDRA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.marketwatch.com/investing/stock/IDRA
IDRA | Complete Idera Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://finance.yahoo.com/quote/IDRA
The current stock performance of Idera Pharmaceuticals shows a 52-week-high of $6.14 and a 52-week-low of $1.05. Moreover, at the end of the last trading period, the closing price was at $5.21 ...
https://stocktwits.com/symbol/IDRA
IDRA Idera Pharmaceuticals, Inc. — Stock Price and Discussion | Stocktwits. Idera Pharmaceuticals, Inc. NASDAQ Updated Dec 2, 2021 12:56 AM. IDRA 0.61 0.04 (6.13%) Post-Market …
https://www.msn.com/en-us/money/stockdetails/fi-a1vaf2
View the latest IDRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of IDERA PHARMACEUTICALS, INC.. ... After Hours : …
https://marketglobalist.com/2021/05/19/why-idera-pharmaceuticals-inc-idra-stock-plummeted-in-the-after-hours-on-tuesday/
Why Idera Pharmaceuticals Inc (IDRA) stock plummeted in the after-hours on Tuesday? Idera Pharmaceuticals Inc. (IDRA) shares lost 3.77% to trade at $1.02 in the after-market on Tuesday, May 18, 2021. Earlier, IDRA’s stock gained 0.95% to close Tuesday’s session at $1.06.
https://www.tradingday.com/stocks/idra.html
IDRA - Idera Pharmaceuticals, Inc., stock quotes, stock charts, news, financials, short interest, message boards, insiders, holders, calendars, competitors ...
https://stockstelegraph.com/idera-pharmaceuticals-inc-idra-stock-plummeted/
Idera Pharmaceuticals Inc. (IDRA) Stock Plummeted in the after-hours session on Thursday, March 19, 2021, the stock went 62.57% down in the after-hours session. On March 18, 2021, IDRA announced that the ILLUMINATE-301 trial of tilsotolimod in combination with ipilimumab did not meet its primary endpoint of objective response rate (ORR). The results showed an ORR of 8.8% for the …
Searching for Idra Stock After Hours?
You can just click the links above. The info is collected for you.
